Autologous Platelet Gel in Wound Healing of Coronary Artery Bypass Grafting (CABG) Patients
- Conditions
- InfectionWounds
- Interventions
- Biological: autologous platelet gel
- Registration Number
- NCT00672672
- Lead Sponsor
- University of Nebraska
- Brief Summary
This study will determine if autologous platelet gel (APG) on sternal incision and conduit sites will improve wound healing and decrease infection in coronary artery bypass grafting surgery patients.
- Detailed Description
The purpose of this study is to determine if the use of autologous platelet gel (APG) on sternal incision and conduit sites will improve wound healing and decrease the incidence of infection in patients undergoing coronary artery bypass grafting surgery
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- Any patient who meets criteria and consents to undergo a CABG procedure involving conduit sites and consents to this study.
- Any patient, after inclusion, whom is later determined to have had on-going therapy that could influence wound healing such as radiation or chemotherapy, extensive steroid use, or accidental trauma such as burns, etc.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control (No platelet gel) autologous platelet gel Participants do not receive platlet gel. Platelet Gel autologous platelet gel Participants receive platlet gel.
- Primary Outcome Measures
Name Time Method Healing and infection of surgical sites 30 days The surgical sites will be assessed for degree of healing and signs and symptoms of infection on post-op days one and three and during the patients' follow up visits in the clinic.
- Secondary Outcome Measures
Name Time Method